Loading clinical trials...
Loading clinical trials...
Phase II Protocol for Risk-adapted Stereotactic Body Radio Therapy for Stage T1-T3N0 Non-Small Cell Lung Carcinoma
Conditions
Interventions
Radiotherapy (Fractionated stereotactic body radiation)
Locations
1
Belgium
UZ Brussel Radiotherapie dienst
Jette, Brussels Capital, Belgium
Start Date
January 1, 2013
Primary Completion Date
December 1, 2017
Last Updated
September 9, 2014
NCT04585750
NCT07362459
NCT07050043
NCT04853342
NCT06899789
NCT06222489
Lead Sponsor
Universitair Ziekenhuis Brussel
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions